Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)
RecruitingNot applicableNCT06214949
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to assess the efficacy of Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) therapy to reduce chronic neck for military health system beneficiaries.
Study details
- Official title
- Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) as a Treatment for Chronic Neck Pain
- Conditions
- Interventions
- Device: Personalized Repetitive Transcranial Magnetic Stimulation
- Device: Sham Personalized Repetitive Transcranial Magnetic Stimulation
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Collaborators
- Uniformed Services University of the Health Sciences; Walter Reed National Military Medical Center
- Start date
- 2024-05-01
- Primary completion
- 2027-05
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Military health care beneficiary for enrollment. * Over the age of 18 years. * Presence of chronic neck pain for at least 3 months. Exclusion Criteria: * History of seizure, bipolar disorder, or schizophrenia. * Unstable heart or pulmonary disease. * Brain tumor, active brain infection, history of cerebral vascular accident (CVA), or penetrating brain injury. * Use of medications that potentially lower seizure threshold without concomitant administration of anticonvulsant drugs that may protect against seizure occurrence. 1. Antiviral medications and antipsychotic medications 2. Recent withdrawal from sedatives 3. Substance abuse of phencyclidine, amphetamines, ketamine, and gammahydroxybutyrate * Not a suitable candidate for the study as determined by the PI. * Pregnancy, breastfeeding, or plans to become pregnant during the course of the study. * Presence of metallic hardware in close contact to the discharging coil (e.g. cochlear implants, internal pulse generator). * Presence of implanted brain electrodes (cortical or deep-brain electrodes). * Potential participants who score above a certain suicide relevant survey score on the Suicide Behaviors Questionnaire-Revised (SBQ-R), or are judged by expert clinicians to be a serious risk of harm to self, will be excluded. * Participants cannot have undergone a previous TMS treatment within the last 30 days before the start of study treatment. * Participants must have reliable and consistent access to the internet to complete surveys when not present in the clinic. * Participants must not have a clinical diagnosis of insomnia. * Participants can not be actively partaking in a substance abuse program.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06214949